Literature DB >> 21732317

Simultaneous single-molecule mapping of protein-DNA interactions and DNA methylation by MAPit.

Carolina E Pardo1, Russell P Darst, Nancy H Nabilsi, Amber L Delmas, Michael P Kladde.   

Abstract

Sites of protein binding to DNA are inferred from footprints or spans of protection against a probing reagent. In most protocols, sites of accessibility to a probe are detected by mapping breaks in DNA strands. As discussed in this unit, such methods obscure molecular heterogeneity by averaging cuts at a given site over all DNA strands in a sample population. The DNA methyltransferase accessibility protocol for individual templates (MAPit), an alternative method described in this unit, localizes protein-DNA interactions by probing with cytosine-modifying DNA methyltransferases followed by bisulfite sequencing. Sequencing individual DNA products after amplification of bisulfite-converted sequences permits assignment of the methylation status of every enzyme target site along a single DNA strand. Use of the GC-methylating enzyme M.CviPI allows simultaneous mapping of chromatin accessibility and endogenous CpG methylation. MAPit is therefore the only footprinting method that can detect subpopulations of molecules with distinct patterns of protein binding or chromatin architecture and correlate them directly with the occurrence of endogenous methylation. Additional advantages of MAPit methylation footprinting as well as considerations for experimental design and potential sources of error are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732317      PMCID: PMC3214598          DOI: 10.1002/0471142727.mb2122s95

Source DB:  PubMed          Journal:  Curr Protoc Mol Biol        ISSN: 1934-3647


  73 in total

Review 1.  Chromatin remodelling: the industrial revolution of DNA around histones.

Authors:  Anjanabha Saha; Jacqueline Wittmeyer; Bradley R Cairns
Journal:  Nat Rev Mol Cell Biol       Date:  2006-06       Impact factor: 94.444

Review 2.  Chromatin modifications and their function.

Authors:  Tony Kouzarides
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 3.  The role of chromatin during transcription.

Authors:  Bing Li; Michael Carey; Jerry L Workman
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

4.  Single-molecule and population probing of chromatin structure using DNA methyltransferases.

Authors:  Jessica A Kilgore; Scott A Hoose; Tanya L Gustafson; Weston Porter; Michael P Kladde
Journal:  Methods       Date:  2007-03       Impact factor: 3.608

5.  Differential transcriptional regulation by mouse single-minded 2s.

Authors:  Richard P Metz; Hyeong-Il Kwak; Tanya Gustafson; Brian Laffin; Weston W Porter
Journal:  J Biol Chem       Date:  2006-02-09       Impact factor: 5.157

6.  DNA methyltransferase probing of DNA-protein interactions.

Authors:  Scott A Hoose; Michael P Kladde
Journal:  Methods Mol Biol       Date:  2006

Review 7.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

8.  Inhibition of breast cancer growth and invasion by single-minded 2s.

Authors:  Hyeong-Il Kwak; Tanya Gustafson; Richard P Metz; Brian Laffin; Pepper Schedin; Weston W Porter
Journal:  Carcinogenesis       Date:  2006-07-13       Impact factor: 4.944

9.  Constitutive nucleosome depletion and ordered factor assembly at the GRP78 promoter revealed by single molecule footprinting.

Authors:  Einav Nili Gal-Yam; Shinwu Jeong; Amos Tanay; Gerda Egger; Amy S Lee; Peter A Jones
Journal:  PLoS Genet       Date:  2006-09-22       Impact factor: 5.917

10.  Inheritance of an epigenetic mark: the CpG DNA methyltransferase 1 is required for de novo establishment of a complex pattern of non-CpG methylation.

Authors:  Valérie Grandjean; Ruken Yaman; François Cuzin; Minoo Rassoulzadegan
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

View more
  7 in total

1.  Local depletion of DNA methylation identifies a repressive p53 regulatory region in the NEK2 promoter.

Authors:  Nancy H Nabilsi; Daniel J Ryder; Ashley C Peraza-Penton; Rosha Poudyal; David S Loose; Michael P Kladde
Journal:  J Biol Chem       Date:  2013-10-25       Impact factor: 5.157

2.  Human lymphoid translocation fragile zones are hypomethylated and have accessible chromatin.

Authors:  Zhengfei Lu; Michael R Lieber; Albert G Tsai; Carolina E Pardo; Markus Müschen; Michael P Kladde; Chih-Lin Hsieh
Journal:  Mol Cell Biol       Date:  2015-01-26       Impact factor: 4.272

3.  DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11.

Authors:  Smitha R James; Carlos D Cedeno; Ashok Sharma; Wa Zhang; James L Mohler; Kunle Odunsi; Elizabeth M Wilson; Adam R Karpf
Journal:  Epigenetics       Date:  2013-07-09       Impact factor: 4.528

4.  DNA methyltransferase accessibility protocol for individual templates by deep sequencing.

Authors:  Russell P Darst; Nancy H Nabilsi; Carolina E Pardo; Alberto Riva; Michael P Kladde
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

5.  High Fractional Occupancy of a Tandem Maf Recognition Element and Its Role in Long-Range β-Globin Gene Regulation.

Authors:  Jared R Stees; Mir A Hossain; Tomoki Sunose; Yasushi Kudo; Carolina E Pardo; Nancy H Nabilsi; Russell P Darst; Rosha Poudyal; Kazuhiko Igarashi; Suming Huang; Michael P Kladde; Jörg Bungert
Journal:  Mol Cell Biol       Date:  2015-10-26       Impact factor: 4.272

6.  Epigenetic diversity of Kaposi's sarcoma-associated herpesvirus.

Authors:  Russell P Darst; Irina Haecker; Carolina E Pardo; Rolf Renne; Michael P Kladde
Journal:  Nucleic Acids Res       Date:  2013-01-29       Impact factor: 16.971

7.  Multiplex mapping of chromatin accessibility and DNA methylation within targeted single molecules identifies epigenetic heterogeneity in neural stem cells and glioblastoma.

Authors:  Nancy H Nabilsi; Loic P Deleyrolle; Russell P Darst; Alberto Riva; Brent A Reynolds; Michael P Kladde
Journal:  Genome Res       Date:  2013-10-08       Impact factor: 9.043

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.